期刊文献+

藜草花粉变应原免疫活性分析 被引量:1

Immunoactivity analysis of album pollen allergen
下载PDF
导出
摘要 目的:分析藜草花粉变应原成分及其变应原性、免疫原性.方法:用Sephacryl S-200HR葡聚糖凝胶层析法分离、纯化藜草花粉变应原,通过十二烷硫酸钠-聚丙烯酰胺凝胶电脉法(SDS—PAGE)测定变应原各组分的分子质量;应用免疫印迹法检测各组分蛋白质与藜草花粉过敏性哮喘患者血清中sIgG和sIgE的反应率.结果:藜草花粉经电泳后得到12条蛋白质区带,分子质量依次为92,63.1,61,52,45,43,39.7,38.9,34,31.6,28.4和18.5~12ku;免疫印迹可见4条sIgE反应带,蛋白分子质量依次为92,34,31.6和18.5~12ku;与患者血清反应率分别是70%,50%,80%和90%;与血清sIgG结合的反应带有8条,蛋白分子质量为92,61,52,45,43,39.7,31.6和18.5~12ku;与患者血清反应率分别是80%,40%,10%,20%,80%,10%,10%和100%.结论:藜草花粉变应原主要含12种蛋白质成分,其中分子质量为18.5—12ku和92ku的蛋白质变应原活性及免疫原活性均很强,是主要变应原成分;分子质量在34和31.6ku的蛋白质有较强的变应原性而无或仅有较弱的免疫原性;而分子质量为43,61,45,52和39.7ku的蛋白质具有一定的免疫原性而无变应原性. AIM: To analyse protein components in album pollen and evaluate their aUergenicity and immunogenicity. METHODS: The components of protein allergen were collected from the crude extract of chenopodium album pollen with Sephacryl S-200 HR gel filtration for removing the impurities. Molecular weights of the components were tested through SDS-PAGE. Then the reaction rates of IgE and IgG in asthmatic patients serum to chenopodium album pollen were counted by immunoblotting. RESULTS: Twelve bands of protein were obtained through SDS- PAGE. The molecular weight of each band was 92, 63.1, 61, 52, 45, 43, 39.7, 38.9, 34, 31.6, 28.4 and 18.5 -12 ku. Immunobloting identified 4 protein bands recognized by sIgE, molecular weights being 92, 34, 31.6 and 18.5 - 12 ku, which reacted with 70% , 50% , 80% and 90% of asthmatic patient serum. Eight protein bands with molecular weights being 92, 61, 52, 45, 43, 39.7, 31.6 and 18.5 - 12 ku showed slgG binding capacity, which reacted with 80%, 40%, 10%, 20%, 80%, 10%, 10% and 100% of asthmatic patient serum. CONCLUSION: Album pollen comprises 12 major protein components. Components with strong allergenicity and immunogenicity are the proteins with molecular weight of 18.5 - 12 and 92 ku. Proteins with molecular weight of 34 and 31.6 ku have strong allergenicity, and weak immunogenicity or not. Proteins with molecular weight of 61,43,45,52 and 39.7 ku possess certain immunogenicity, but no allergenicity.
出处 《第四军医大学学报》 CAS 北大核心 2007年第4期334-337,共4页 Journal of the Fourth Military Medical University
基金 陕西省卫生厅基金资助(02D20)
关键词 哮喘 藜草 花粉 变应原 变应原性 免疫原性 asthma chenopodium album pollen allergens allergenicity immunogenicity
  • 相关文献

参考文献6

  • 1叶世泰.中国气传致敏花粉调查[M].北京:北京出版社,1991.8-12.
  • 2中华医学会呼吸病学分会哮喘学组.支气管哮喘防治指南(支气管哮喘的定义、诊断、治疗及教育和管理方案)[J].中华结核和呼吸杂志,2003,26(3):132-138. 被引量:3565
  • 3Ipsen H,Klysner SS,Marsen JN,et al.Allergenic extracts[A]//Milddleton Jt.E,Reed CE,llis EF,et al,Allergy Principle and Practice.4th ed[M].St,Louis:Mosby,1993:529.
  • 4Nakada S.Allergenicity and immunogenic components of house dustmite Derma to phagoidesfarine[J].Ann Allergy,1986,56(2):150-155.
  • 5Bousquet J.Specific immunotherapy in asthma[J].Allergy,1999,54:37-38.
  • 6Nahm DH.Seasonal variation of IgG sub class antibodies to house-Dust mite in ser a from mite-sensitive asthma tic patients[J].Ann Allergy Asthma Immunol,1998,80(5):411-415.

共引文献3575

同被引文献8

  • 1Tulic MK, Fiset PO, Christodoulopoulos P, et al. Arab al-immunos- timulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response[J]. J Allergy Clin Immunol, 2004, 113 (2) : 235 -241.
  • 2Futamura N, Mukai Y, Sakaguchi M, et al. Isolation and character- ization of cDNAs that encode homologs of a pathogenesis-related pro- tein allergen from cryptomeria japonica [ J ]. Biosci Biotechnol Bio- chem, 2002, ( 11 ) : 2495 - 2500.
  • 3Reuter A, Fortunato D, Garoffo LP, et al. Novel isoforms of Pru avlwith diverging immunoglobulin E binding properties identified by a synergistic combination of molecular biology and proteomies[ J]. Pro- teomics, 2005, 5 ( 1 ) : 282 - 289.
  • 4Rio DC, Ares M Jr, Hannon GJ, et al. Purification of RNA using TR- Izol (TRI reagent) [J]. Cold Spring Harb Protoc, 2010, doi: 10. 1 101/pdb, prot5439.
  • 5Hagen A, Gorenoi V, Schonermark MP. Specific immunotherapy (SIT) in the treatment of allergic rhinitis [ J]. GMS Health Technol Assess, 2010, doi: 10.3205/hta000079.
  • 6Kuna P, Kaczmarek J, Kupczyk M. Efficacy and safety of immuno- therapy for allergies to alternata in children[J]. J Allergy Clin Immu- nol, 2011, 127(2): 502-508. e1 -6.
  • 7Larche M, Akdis CA, Valenta R. Immunological mechanisms of aller- gen-specific immunotherapy [ J ]. Nat Rev Immunol, 2006, 6 ( 10 ) : 761 -771.
  • 8Whalen RG, Kaiwar R, Soong NW, et al. DNA shuffling and vac- cines[J]. Curr Opin Mol Ther, 2001, 3(1) : 31 -35.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部